Insomnia due to hypnotic abuse
Abstract
Insomnia due to hypnotics abuse and dependence is a common and serious problem of somnology irrespectively of which one comes first: sleep disturbances or drug use. Modern hypnotics demonstrates selective affinity to some types of benzodiazepine receptors. This explains its higher safety profile than for first-generation hypnotics. Nevertheless there are reports of dependence and withdrawal syndrome associated with its administration as well. The most dangerous symptoms of withdrawal are seizures, hemodynamic and respiratory disturbances. Treatment of a hypnotic dependence includes detoxication and gradual withdrawal of medicines.
About the Authors
M. G. Poluektov
I.M. Sechenov Moscow State Medical University
Russian Federation
Russian Federation
P. V. Pchelina
I.M. Sechenov Moscow State Medical University
Russian Federation
Russian Federation
References
1. Ancoli-Israel S. Insomnia in the elderly: a review for the primary care practitioner. - Sleep.- 2000. - Vol. 23. - S. 30.
2. American Psychiatric Association. DSM-V, Diagnostic and Statistical Manual of Mental Disorders, 5th edition. Washington, DC. - American Psychiatric Publishing. - 2013.
3. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed.: Diagnostic and coding manual. Westchester, Ill. - American Academy of Sleep Medicine. - 2005.
4. American Academy of Sleep Medicine. The International classification of sleep disorders [Diagnostic and coding manual]. - Darien, U.S.A. - American Academy of Sleep Medicine. - 2014.
5. Johnson E.O., Breslau N. Sleep problems and substance use in adolescence. - Drug and Alcohol Dependence. - 2001. - V. 62. - P. 1-7.
6. Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. - Rockville, MD: Department of Health and Human Services (HHS). - 2015.
7. Breslau N., Roth T., Rosenthal L., Andreski P. Sleep disturbance and psychiatric disorder: a longitudinal epidemiological study of young adults. - Biological Psychiatry. - 1996. -V. 39. - P. 411-418.
8. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality.The TEDS Report: Substance Abuse Treatment Admissions for Abuse of Benzodiazepines. - Rockville, MD: Department of Health and Human Services (HHS). - 2011.
9. Голенков А.В., Полуэктов М.Г. Распространенность нарушений сна у жителей Чувашии (данные сплошного анкетного опроса). - Журнал неврологии и психиатрии им. С.С. Корсакова. - 2011. - T. 111. - C. 64-67.
10. Mellinger G.D.; Balter M.B., Uhlenhuth E.H. Insomnia and its treatment. Prevalence andcorrelates. - Archives of General Psychiatry. - 1985. - V. 42. - P. 225-232.
11. Walsh JK, Roth T Pharmacologic treatment of insomnia: benzodiazepine receptor agonists. In: M.H. Kryger, T. Roth, W.C. Dement. Eds. Principles and practice of sleep medicine - 5th ed. St. Louis, Missouri: Elsevier Saunders. - 2011.
12. Vimont C. Sleep Problems and Substance Use Disorders: An Often Overlooked Link. July 26, 2013. Доступно по http://www.drugfree.org/join-together/ sleep-problems-and-substance-use-disorders-an-of-ten-overlooked-link/. По состоянию на 15.10.2015
13. Mahfoud Y., Talih F., Streem D., Budur K. Sleep disorders in substance abusers: how common are they? - Psychiatry (Edgemont.). - 2009. - Vol. 6. - P. 38-42.
14. Roth T. Insomnia: Definition, Prevalence, Etiology, and Consequences. Journal of Clinical Sleep Medicine. 2007; 3(5 Suppl):7-10. doi: 10.1016/s1098-3597(03)90031-7
15. Полуэктов М.Г., Левин Я.И. (ред). Сомнология и медицина сна. - Москва: Медфорум. - 2013.
16. Ensrud K.E., Blackwell T.L., Mangione C.M., Bowman P.J., Whooley M.A., Bauer D.C., Schwartz A.V., Hanlon J.T., Nevitt M.C. Central nervous system-active medications and risk for falls in older women. - Journal of American Geriatric Society. - 2002. - Vol. 50. - P. 1629-1637.
17. Kessler R.C., McGonagle K.A., Shanyang Z., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States Results From the National Comorbidity Survey. - Archives of General Psychiatry -1994. - Vol. 51. - P. 8-19.
18. Pagel J.F., Parnes B.L. Medications for the treatment of sleep disorders: an overview. - Journal of clinical psychiatry. - 2001. - Vol.3. - P. 118-125.
19. Vinkers C.H., Olivier B. Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA-A Receptor Modulators?-Advances in Pharmacological Sciences. - 2012. - Vol. 2. - P. 1-19.
20. Wojcik S.M., Tantra M., Stepniak B., Man K.M., Müller-Ribbe K., Begemann M., Ju A., Papiol S., Ronnenberg A., Gurvich A., Shin Y., Augustin I., Brose N., Ehrenreich H. Genetic Markers of a Munc13 Protein Family Member, BAIAP3, Are Gender Specifically Associated with Anxiety and Benzodiazepine Abuse in Mice and Humans. - Molecular Medicine. - 2013. - Vol. 19. - P. 135-148.
21. Kolb B., Whishaw I. An Introduction to Brain and Behavior. -New York: Worth Publishers. - 2014. Print.
22. Roehrs T, Merlotti L, Zorick F, Roth T. Rebound insomnia and hypnotic self administration. - Psycho-pharmacology. - 1992. - Vol. 107. - P. 480-484.
23. Tsai MJ, Huang YB, Wu PC. A novel clinical pattern of visual hallucination after zolpidem use. - Journal of Toxicology: Clinical Toxicology. - 2003. - Vol. 41. - P. 869-872.
24. Полуэктов М.Г., Левин Я.И., Михайлов В.А., Бабак С.Л., Стрыгин К.Н. Применение триттико (тразодона) для лечения нарушений сна при депрессии: результаты мультицентрового исследования. - Эффективная фармакотерапия. - 2013. - № 12. - С. 82-90.
25. Weaver MD. Prescription Sedative Misuse and Abuse. - Yale Journal of biology and medicine. - 2015. - Vol. 88. - P. 247-256.
Review
For citations:
Poluektov M.G., Pchelina P.V. Insomnia due to hypnotic abuse. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2017;(1):75-80. (In Russ.)
Views:
472
Email this article 